1. Brief Report: CYP2B6 516G>T Minor Allele Protective of Late Virologic Failure in Efavirenz-Treated HIV-Infected Patients in Botswana. (1st August 2017) Authors: Vujkovic, Marijana; Bellamy, Scarlett L.; Zuppa, Athena F.; Gastonguay, Marc; Moorthy, Ganesh S.; Ratshaa, Bakgaki R.; Han, Xiaoyan; Steenhoff, Andrew P.; Mosepele, Mosepele; Strom, Brian L.; Aplenc, Richard; Bisson, Gregory P.; Gross, Robert Journal: Journal of acquired immune deficiency syndromes Issue: Volume 75:Number 4(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CYP2B6 genotypes and early efavirenz-based HIV treatment outcomes in Botswana. (24th September 2017) Authors: Gross, Robert; Bellamy, Scarlett L.; Ratshaa, Bakgaki; Han, Xiaoyan; Vujkovic, Marijana; Aplenc, Richard; Steenhoff, Andrew P.; Mosepele, Mosepele; Moorthy, Ganesh; Zuppa, Athena F.; Strom, Brian L.; Bisson, Gregory P. Journal: AIDS Issue: Volume 31:Number 15(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Early Antiretroviral Therapy Is Protective Against Epilepsy in Children With Human Immunodeficiency Virus Infection in Botswana. (1st June 2015) Authors: Bearden, David; Steenhoff, Andrew P.; Dlugos, Dennis J.; Kolson, Dennis; Mehta, Parth; Kessler, Sudha; Lowenthal, Elizabeth; Monokwane, Baphaleng; Anabwani, Gabriel; Bisson, Gregory P. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 69(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effects of sex and alcohol use on antiretroviral therapy outcomes in Botswana: a cohort study. (7th September 2016) Authors: Gross, Robert; Bellamy, Scarlett L.; Ratshaa, Bakgaki; Han, Xiaoyan; Steenhoff, Andrew P.; Mosepele, Mosepele; Bisson, Gregory P. Journal: Addiction Issue: Volume 112:Number 1(2017) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Elevated Pre–Antiretroviral Therapy CD39+CD8+ T Cell Frequency Is Associated With Early Mortality in Advanced Human Immunodeficiency Virus/Tuberculosis Co-infection. (16th February 2017) Authors: Ravimohan, Shruthi; Tamuhla, Neo; Nfanyana, Kebatshabile; Ni, Houping; Steenhoff, Andrew P.; Gross, Robert; Weissman, Drew; Bisson, Gregory P. Journal: Clinical infectious diseases Issue: Volume 64:Number 10(2017) Page Start: 1453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. First Use of Multiple Imputation with the National Tuberculosis Surveillance System. (30th January 2013) Authors: Vinnard, Christopher; Wileyto, E. Paul; Bisson, Gregory P.; Winston, Carla A. Other Names: Burger Huibert Academic Editor. Journal: Epidemiology research international Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Hepatotoxicity During Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living With HIV With Severe Immunosuppression: A Secondary Analysis of a Multi-Country Open-Label Randomized Controlled Clinical Trial. (1st May 2018) Authors: Ngongondo, McNeil; Miyahara, Sachiko; Hughes, Michael D.; Sun, Xin; Bisson, Gregory P.; Gupta, Amita; Kumwenda, Johnstone; Lavenberg, Jeffrey A.; Torres, Thiago Silva; Nyirenda, Mulinda; Kidonge, Katende Kenneth; Hosseinipour, Mina C. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 78:Number 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation. (9th December 2016) Authors: Vinnard, Christopher; Ravimohan, Shruthi; Tamuhla, Neo; Ivaturi, Vijay; Pasipanodya, Jotam; Srivastava, Shashikant; Modongo, Chawangwa; Zetola, Nicola M.; Weissman, Drew; Gumbo, Tawanda; Bisson, Gregory P. Journal: British journal of clinical pharmacology Issue: Volume 83:Number 4(2017:Apr.) Page Start: 801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB. (2nd May 2017) Authors: Vinnard, Christopher; Ravimohan, Shruthi; Tamuhla, Neo; Pasipanodya, Jotam; Srivastava, Shashikant; Modongo, Chawangwa; Zetola, Nicola M.; Weissman, Drew; Gumbo, Tawanda; Bisson, Gregory P. Journal: Journal of antimicrobial chemotherapy Issue: Volume 72:Number 7(2017:Jul.) Page Start: 2020 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pharmacogenetic variability and the probability of site of action target attainment during tuberculosis meningitis treatment: A physiologically based pharmacokinetic modeling and simulations study. (December 2022) Authors: Mehta, Krina; Narayanan, Navaneeth; Heysell, Scott K.; Bisson, Gregory P.; Subbian, Selvakumar; Kurepina, Natalia; Kreiswirth, Barry N.; Vinnard, Christopher Journal: Tuberculosis Issue: Volume 137(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗